SCHEMBL2324995

SCHEMBL2324995

NC(=O)c1cc(CCS(=O)(=O)O)ccn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 3/20 0.40
CYP4A11 Q02928 2/20 0.40
NR3C2 P08235 9/20 0.38
LOXL2 Q9Y4K0 1/20 0.37
ADORA3 P0DMS8 1/20 0.36
TSHR P16473 1/20 0.36
MC4R P32245 1/20 0.36
ADRA1A P35348 1/20 0.36
MC3R P41968 1/20 0.36
CSF1R P07333 1/20 0.35
GRM2 Q14416 1/20 0.35
IGF1R P08069 1/20 0.35
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9339179 0.80 LOXL2 (0.44) CYP4F2CYP4A11NR3C2LOXL2ADORA3
SCHEMBL3129466 0.79 CYP4F2 (0.42) CYP4F2CYP4A11NR3C2LOXL2ADORA3
SCHEMBL16594468 0.79 NR2F2 (0.43) CYP4F2CYP4A11NR3C2LOXL2ADORA3
SCHEMBL8847552 0.78 LMNA (0.36) NR3C2TSHRGABRPGABRDGABRA1
SCHEMBL1419538 0.78 CYP4F2 (0.44) CYP4F2CYP4A11NR3C2LOXL2ADORA3
SCHEMBL2328151 0.76 RECQL (0.50) CYP4F2CYP4A11NR3C2LOXL2ADORA3
SCHEMBL20377228 0.76 CYP4F2 (0.45) CYP4F2CYP4A11NR3C2LOXL2ADORA3
SCHEMBL2176535 0.76 LOXL2 (0.56) CYP4F2CYP4A11LOXL2ADORA3TSHR
SCHEMBL30193091 0.76 RECQL (0.50) CYP4F2CYP4A11NR3C2LOXL2ADORA3
SCHEMBL1388918 0.76 GRM2 (0.46) CYP4F2CYP4A11NR3C2LOXL2ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2356112-A1 HETEROAROMATIC COMPOUNDS FOR USE AS HIF INHIBITORS Bayer Schering Pharma Aktiengesellschaft (DE) 2011-08-17 EP disclosed
WO-2010054764-A1 HETEROAROMATIC COMPOUNDS FOR USE AS HIF INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-05-20 WO disclosed